Mary F. Brunette, MD
Associate Professor of Psychiatry
Medical Director of the Bureau of Mental Health Services, New Hampshire Department of Health and Human Services
Co-DIrector Community Engaged Research Core, Dartmouth SYNERGY, CTSA
Chairman, NH DHHS Committee for the Protection of Human Subjects
Co-Investigator, Center for Technology and Behavioral Health
Lewis & Clark College, BA 1985
Oregon Health Sciences University, MD 1991
C. Everett Koop Institute at Dartmouth
Norris Cotton Cancer Center
Psychopharmacology Research Group
Department of Psychiatry, Dartmouth-Hitchcock
Center for Technology and Behavioral Health
46 Centerra Parkway, level 2
Lebanon NH 0
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
Workshop on the Development and Evaluation of Digital Therapeutics for Health Behavior Change: Science, Methods, and Projects.
Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial.
Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder.
The Opioid Epidemic and Psychiatry: The Time for Action Is Now.
Adolescents' Use of Digital Technologies and Preferences for Mobile Health Coaching in Public Mental Health Settings.
Use of Smartphones, Computers and Social Media Among People with SMI: Opportunity for Intervention.
Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness.
Incentivizing healthy lifestyle behaviors to reduce cardiovascular risk in people with serious mental illness: An equipoise randomized controlled trial of the wellness incentives program.
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.